JNJ-90301900 (NBTXR3)
NANORAY-312
Phase 3 small_molecule active
Quick answer
JNJ-90301900 (NBTXR3) for Carcinoma, Squamous Cell is a Phase 3 program (small_molecule) at Johnson & Johnson Pharmaceutical Research & Development, L.L.C. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Indication
- Carcinoma, Squamous Cell
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active